TriCert Investment Counsel Inc.’s Medtronic MDT Stock Holding History

TriCert Investment Counsel Inc.’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.32M	Buy	+93,570	New	+$7.55M	0.68%	47

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

TriCert Investment Counsel Inc.'s MDT Position: Q2 2026 in Review

TriCert Investment Counsel Inc. opened a new position in Medtronic (MDT) in Q2 2026: 93,570 shares worth $7.32M. The stake represents 0.68% of the portfolio and ranks #47 among its holdings.

1,424 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

TriCert Investment Counsel Inc. held 93,570 shares of Medtronic worth $7.32M as of Q2 2026.
Medtronic was a new TriCert Investment Counsel Inc. position in Q2 2026.
Medtronic made up 0.68% of TriCert Investment Counsel Inc.'s portfolio in Q2 2026, its #47 holding.
1,424 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TriCert Investment Counsel Inc.'s 13F filing for Q2 2026, filed 10 Aug 2026.